Abstract:Systemic study of pathogenic pathways and interrelationships underlying genes associated with Alzheimer's disease (AD) facilitates the identification of new targets for effective treatments. Recently available large-scale multi-omics datasets provide opportunities to use computational approaches for such studies. Here, we devised a novel disease gene identification (digID) computational framework that consists of a semi-supervised deep learning classifier to predict AD-associated genes and a protein-protein interaction (PPI) network-based analysis to prioritize the importance of these predicted genes in AD. digID predicted 1,529 AD-associated genes and revealed potentially new AD molecular mechanisms and therapeutic targets including GNAI1 and GNB1, two G-protein subunits that regulate cell signaling, and KNG1, an upstream modulator of CDC42 small G-protein signaling and mediator of inflammation and candidate coregulator of amyloid precursor protein (APP). Analysis of mRNA expression validated their dysregulation in AD brains but further revealed the significant spatial patterns in different brain regions as well as among different sub-regions of frontal cortex and hippocampi. Super-resolution STochastic Optical Reconstruction Microscopy (STORM) further demonstrated their subcellular co-localization and molecular interactions with APP in a transgenic mouse model of both sexes with AD-like mutations. These studies support the predictions made by digID while highlighting the importance of concurrent biological validation of computationally identified gene clusters as potential new AD therapeutic targets.Significance Statement Powerful computational approaches such as machine learning (ML) can interrogate large-scale multi-omics datasets to predict disease-associated genes unbiasedly via systemic study. This study presents a new disease gene identification (digID) computational framework using semi-supervised deep learning classifier. Empowered by the super-resolution imaging and the spatial biology paradigm, we further revealed that the ML model predicted AD-related G-protein signaling is subject to spatial expression dysregulation. Therefore, computational discoveries require independent biological validation to yield medical insights and our data highlight three novel G-protein genes and their signaling networks to be potential new AD therapeutic targets.

Identification of Alzheimer associated differentially expressed gene through microarray data and transfer learning-based image analysis

Identifying Shared Diagnostic Genes and Mechanisms in Vascular Dementia and Alzheimer's Disease Via Bioinformatics and Machine Learning

Identification of candidate biomarkers and signaling pathways associated with Alzheimer's disease using bioinformatics analysis of next generation sequencing data

Identification of Endoplasmic Reticulum Stress-Associated Genes and Subtypes for Prediction of Alzheimer’s Disease Based on Interpretable Machine Learning

Integrated Identification of Key Genes and Pathways in Alzheimer’s Disease Via Comprehensive Bioinformatical Analyses

Unveiling biomarker detection in Alzheimer's disease: a computational approach to microarray analysis

Identification of microRNA-mRNA Regulatory Networks with Therapeutic Values in Alzheimer's Disease by Bioinformatics Analysis

Identifying the Role of Oligodendrocyte Genes in the Diagnosis of Alzheimer's Disease Through Machine Learning and Bioinformatics Analysis.

Identification of neutrophil extracellular trap-related genes in Alzheimer's disease based on comprehensive bioinformatics analysis

Key Genes and Biochemical Networks in Various Brain Regions Affected in Alzheimer’s Disease

Exploring Potential Biomarkers Underlying the Pathogenesis of Alzheimer's Disease by Bioinformatics Gene Analysis.

G-Protein Signaling in Alzheimer's Disease: Spatial Expression Validation of Semi-Supervised Deep Learning Based Computational Framework

Deep Learning-Based Prediction of Alzheimer's Disease Using Microarray Gene Expression Data

Identification of biomarkers differentiating Alzheimer's disease from other neurodegenerative diseases by integrated bioinformatic analysis and machine-learning strategies

Investigating gene expression datasets of hippocampus tissue to discover Alzheimer's disease-associated molecular markers

The Bioinformatic Analysis of the Dysregulated Genes and MicroRNAs in Entorhinal Cortex, Hippocampus, and Blood for Alzheimer's Disease.

Exploiting Machine Learning Models to Identify Novel Alzheimer’s Disease Biomarkers and Potential Targets

Comprehensive Analysis Reveals A Six-Gene Signature and Associated Drugs in Alzheimer Disease

Identification of Diagnostic Biomarkers in Alzheimer's Disease by Integrated Bioinformatic Analysis and Machine Learning Strategies.

An Integrated Genetics Approach for Identifying Protein Signal Pathways of Alzheimer's Disease

Integrated Bioinformatic Analysis and Validation Identifies Immune Microenvironment-Related Potential Biomarkers in Alzheimer’s Disease